Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of proteasome inhibitors for cancer treatment. Its chiral structure makes it valuable in creating biologically active compounds with high specificity. Commonly employed in research settings for designing drugs that target protein degradation pathways, especially in multiple myeloma and other hematologic malignancies. Also utilized in asymmetric synthesis due to its stereochemical stability and functional group compatibility.